Table 4.
Human papillomavirus type-specific distribution in women with cervical cytology abnormalities and ISCC.
| ASCH (n = 149) | ASC-US (n = 640) | HSIL (n = 308) | LSIL (n = 244) | ISCC (n = 223) | |
|---|---|---|---|---|---|
| High risk | |||||
| 16 | 36 (24.16) | 49 (7.66) | 110 (35.71) | 31 (12.70) | 169 (75.78) |
| 18 | 7 (4.70) | 25 (3.91) | 18 (5.84) | 10 (4.10) | 23 (10.31) |
| 31 | 0 (0.00) | 15 (2.34) | 7 (2.27) | 7 (2.87) | 4 (1.79) |
| 33 | 7 (4.70) | 20 (3.13) | 14 (4.55) | 12 (4.92) | 11 (4.93) |
| 35 | 2 (1.34) | 7 (1.09) | 1 (0.32) | 6 (2.46) | 0 (0.00) |
| 39 | 1 (0.67) | 10 (1.56) | 3 (0.97) | 4 (1.64) | 5 (2.24) |
| 45 | 1 (0.67) | 3 (0.47) | 2 (0.65) | 4 (1.64) | 3 (1.35) |
| 51 | 1 (0.67) | 3 (0.47) | 1 (0.32) | 4 (1.64) | 2 (0.90) |
| 52 | 18 (12.08) | 53 (8.28) | 16 (5.19) | 41 (16.80) | 15 (6.73) |
| 53 | 1 (0.67) | 25 (3.91) | 5 (1.62) | 15 (6.15) | 1 (0.45) |
| 56 | 0 (0.00) | 7 (1.09) | 2 (0.65) | 3 (1.23) | 1 (0.45) |
| 58 | 16 (10.74) | 38 (5.94) | 28 (9.09) | 23 (9.43) | 22 (9.87) |
| 59 | 0 (0.00) | 5 (0.78) | 2 (0.65) | 4 (1.64) | 4 (1.79) |
| 66 | 1 (0.67) | 11 (1.72) | 3 (0.97) | 3 (1.23) | 0 (0.00) |
| 68 | 3 (2.01) | 11 (1.72) | 3 (0.97) | 10 (4.10) | 2 (0.90) |
| Low risk | |||||
| 6 | 2 (1.34) | 11 (1.72) | 0 (0.00) | 3 (1.23) | 0 (0.00) |
| 11 | 2 (1.34) | 14 (2.19) | 4 (1.30) | 5 (2.05) | 1 (0.45) |
| 42 | 1 (0.67) | 1 (0.16) | 1 (0.32) | 0 (0.00) | 0 (0.00) |
| 43 | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) |
| 44 | 0 (0.00) | 2 (0.31) | 0 (0.00) | 3 (1.23) | 1 (0.45) |